Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Molecules for administration to ROS1 mutant cancer cells

Molecules for administration to ROS1 mutant cancer cells

US Patent 10682348 · Granted Jun 16, 2020

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Combinations for the treatment of cancer2020
Methods for the treatment of cancer2020
Methods for treating neuroblastoma2020
Methods for treating neuroblastoma2020
Methods for treating neuroblastoma2020
Molecules for administration to ROS1 mutant cancer cells2019
Molecules for administration to ROS1 mutant cancer cells2019
Molecules for administration to ROS1 mutant cancer cells2019
6-amino-7-bicyclo-7-deaza-purine derivatives as protein kinase inhibitors2019
Substituted indazole derivatives active as kinase inhibitors2018
Pyrrolo[2,3-D]pyrimidine derivatives, process for their preparation and their us2017
Pyridyl-and pyrimidinyl-substituted pyrrole-, thiophene- and furane-derivatives 2017